Concepts (130)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Leishmania donovani | 13 | 2026 | 26 | 4.040 |
Why?
|
| Leishmaniasis, Visceral | 12 | 2026 | 22 | 3.670 |
Why?
|
| Macrophages | 15 | 2025 | 655 | 1.790 |
Why?
|
| Leishmania | 7 | 2025 | 34 | 1.630 |
Why?
|
| Leishmaniasis | 6 | 2025 | 41 | 1.550 |
Why?
|
| Leishmaniasis, Cutaneous | 6 | 2024 | 50 | 1.530 |
Why?
|
| CD40 Antigens | 3 | 2024 | 25 | 1.170 |
Why?
|
| Host-Parasite Interactions | 4 | 2024 | 72 | 1.070 |
Why?
|
| Drug Resistance | 3 | 2026 | 247 | 1.040 |
Why?
|
| Mice, Inbred BALB C | 15 | 2026 | 974 | 1.030 |
Why?
|
| Leishmania major | 6 | 2025 | 27 | 1.030 |
Why?
|
| Protozoan Proteins | 5 | 2026 | 130 | 0.910 |
Why?
|
| Cytokines | 9 | 2026 | 1335 | 0.820 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2024 | 185 | 0.790 |
Why?
|
| CD40 Ligand | 1 | 2023 | 65 | 0.790 |
Why?
|
| Toll-Like Receptor 2 | 5 | 2024 | 55 | 0.670 |
Why?
|
| Autoimmune Diseases | 1 | 2023 | 264 | 0.660 |
Why?
|
| Phosphorylcholine | 4 | 2026 | 31 | 0.640 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2020 | 193 | 0.600 |
Why?
|
| Parasites | 3 | 2023 | 34 | 0.550 |
Why?
|
| Leishmaniasis Vaccines | 3 | 2023 | 20 | 0.520 |
Why?
|
| Signal Transduction | 10 | 2026 | 4678 | 0.510 |
Why?
|
| T-Lymphocytes | 1 | 2023 | 1709 | 0.420 |
Why?
|
| Antiprotozoal Agents | 2 | 2026 | 41 | 0.420 |
Why?
|
| Animals | 24 | 2026 | 33862 | 0.400 |
Why?
|
| Protein Isoforms | 3 | 2023 | 419 | 0.380 |
Why?
|
| Mitogen-Activated Protein Kinase 10 | 2 | 2023 | 5 | 0.370 |
Why?
|
| Mice | 17 | 2026 | 18197 | 0.360 |
Why?
|
| Interferon-gamma | 4 | 2024 | 545 | 0.290 |
Why?
|
| ras Proteins | 2 | 2023 | 147 | 0.220 |
Why?
|
| Amphotericin B | 2 | 2026 | 90 | 0.220 |
Why?
|
| Macrophages, Peritoneal | 2 | 2026 | 37 | 0.220 |
Why?
|
| Toll-Like Receptors | 2 | 2023 | 83 | 0.220 |
Why?
|
| Receptors, Immunologic | 1 | 2025 | 124 | 0.220 |
Why?
|
| Virulence Factors | 1 | 2025 | 180 | 0.210 |
Why?
|
| Suppressor of Cytokine Signaling Proteins | 1 | 2023 | 25 | 0.210 |
Why?
|
| Interleukin-7 | 1 | 2023 | 46 | 0.200 |
Why?
|
| Immunity | 2 | 2023 | 179 | 0.200 |
Why?
|
| Transforming Growth Factor beta | 1 | 2026 | 454 | 0.200 |
Why?
|
| T-Lymphocyte Subsets | 2 | 2023 | 197 | 0.200 |
Why?
|
| Spleen | 2 | 2023 | 257 | 0.180 |
Why?
|
| Ligands | 4 | 2024 | 486 | 0.170 |
Why?
|
| Humans | 18 | 2026 | 130483 | 0.170 |
Why?
|
| Protein Kinase C | 1 | 2021 | 112 | 0.170 |
Why?
|
| Mice, Inbred C57BL | 5 | 2025 | 4697 | 0.170 |
Why?
|
| Antimony | 1 | 2020 | 14 | 0.170 |
Why?
|
| Immunotherapy | 1 | 2025 | 752 | 0.160 |
Why?
|
| Sterol Regulatory Element Binding Protein 1 | 1 | 2020 | 31 | 0.160 |
Why?
|
| Vaccines, DNA | 1 | 2020 | 43 | 0.160 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2020 | 92 | 0.150 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2023 | 499 | 0.150 |
Why?
|
| Mammals | 3 | 2024 | 255 | 0.140 |
Why?
|
| Mitochondrial Proteins | 1 | 2020 | 278 | 0.140 |
Why?
|
| Interleukin-1beta | 1 | 2018 | 157 | 0.140 |
Why?
|
| B-Lymphocytes | 1 | 2020 | 509 | 0.130 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2020 | 427 | 0.130 |
Why?
|
| Skin | 1 | 2020 | 543 | 0.130 |
Why?
|
| Prostatic Neoplasms | 1 | 2025 | 1414 | 0.130 |
Why?
|
| Cell Differentiation | 1 | 2023 | 1927 | 0.120 |
Why?
|
| MicroRNAs | 1 | 2022 | 896 | 0.110 |
Why?
|
| Protein Tyrosine Phosphatases, Non-Receptor | 2 | 2024 | 19 | 0.100 |
Why?
|
| Ion Channels | 2 | 2024 | 198 | 0.090 |
Why?
|
| Membrane Proteins | 1 | 2020 | 1603 | 0.090 |
Why?
|
| Chromatography, Liquid | 2 | 2026 | 237 | 0.090 |
Why?
|
| Th1 Cells | 2 | 2023 | 156 | 0.080 |
Why?
|
| Inflammation | 1 | 2018 | 1473 | 0.080 |
Why?
|
| RNA, Small Interfering | 2 | 2024 | 667 | 0.080 |
Why?
|
| Nitric Oxide | 2 | 2026 | 466 | 0.080 |
Why?
|
| Phosphorylation | 2 | 2024 | 1577 | 0.070 |
Why?
|
| Interleukin-10 | 2 | 2020 | 186 | 0.070 |
Why?
|
| Parasite Load | 1 | 2026 | 32 | 0.060 |
Why?
|
| Antimony Sodium Gluconate | 1 | 2026 | 1 | 0.060 |
Why?
|
| Paromomycin | 1 | 2026 | 5 | 0.060 |
Why?
|
| Receptors, Transforming Growth Factor beta | 1 | 2026 | 106 | 0.060 |
Why?
|
| Suppressor of Cytokine Signaling 1 Protein | 1 | 2023 | 10 | 0.050 |
Why?
|
| Suppressor of Cytokine Signaling 3 Protein | 1 | 2023 | 11 | 0.050 |
Why?
|
| Receptors, Interleukin-7 | 1 | 2023 | 27 | 0.050 |
Why?
|
| Cholestanes | 1 | 2023 | 2 | 0.050 |
Why?
|
| Phosphatidylinositol-3,4,5-Trisphosphate 5-Phosphatases | 1 | 2023 | 6 | 0.050 |
Why?
|
| Glycosphingolipids | 1 | 2023 | 12 | 0.050 |
Why?
|
| Toll-Like Receptor 9 | 1 | 2023 | 22 | 0.050 |
Why?
|
| Toll-Like Receptor 3 | 1 | 2023 | 20 | 0.050 |
Why?
|
| Antigen Presentation | 1 | 2023 | 111 | 0.050 |
Why?
|
| Receptors, Interleukin-1 | 1 | 2023 | 25 | 0.050 |
Why?
|
| Interleukin-1 Receptor-Associated Kinases | 1 | 2023 | 21 | 0.050 |
Why?
|
| Lipopeptides | 1 | 2023 | 35 | 0.050 |
Why?
|
| Peptidoglycan | 1 | 2023 | 21 | 0.050 |
Why?
|
| Coculture Techniques | 1 | 2023 | 232 | 0.050 |
Why?
|
| Molecular Docking Simulation | 1 | 2023 | 150 | 0.050 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2023 | 137 | 0.050 |
Why?
|
| Myeloid Differentiation Factor 88 | 1 | 2023 | 93 | 0.050 |
Why?
|
| Receptors, Interferon | 1 | 2022 | 19 | 0.050 |
Why?
|
| MAP Kinase Signaling System | 1 | 2024 | 305 | 0.050 |
Why?
|
| Proteomics | 1 | 2026 | 612 | 0.040 |
Why?
|
| Pathogen-Associated Molecular Pattern Molecules | 1 | 2021 | 5 | 0.040 |
Why?
|
| Receptor Cross-Talk | 1 | 2021 | 36 | 0.040 |
Why?
|
| Down-Regulation | 1 | 2023 | 655 | 0.040 |
Why?
|
| Membrane Glycoproteins | 1 | 2023 | 410 | 0.040 |
Why?
|
| Programmed Cell Death 1 Receptor | 1 | 2022 | 143 | 0.040 |
Why?
|
| Dogs | 1 | 2022 | 615 | 0.040 |
Why?
|
| B7-H1 Antigen | 1 | 2022 | 129 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2023 | 479 | 0.040 |
Why?
|
| Immunomodulation | 1 | 2021 | 81 | 0.040 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2023 | 463 | 0.040 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2023 | 498 | 0.040 |
Why?
|
| Gene Silencing | 1 | 2021 | 230 | 0.040 |
Why?
|
| Interleukin-12 Subunit p35 | 1 | 2020 | 6 | 0.040 |
Why?
|
| Disease Resistance | 1 | 2020 | 22 | 0.040 |
Why?
|
| Vaccines, Attenuated | 1 | 2020 | 173 | 0.040 |
Why?
|
| Interleukin-4 | 1 | 2020 | 145 | 0.040 |
Why?
|
| Lipogenesis | 1 | 2020 | 62 | 0.040 |
Why?
|
| Virulence | 1 | 2020 | 269 | 0.040 |
Why?
|
| Antibodies, Protozoan | 1 | 2020 | 101 | 0.040 |
Why?
|
| Myeloid Cells | 1 | 2020 | 112 | 0.040 |
Why?
|
| Mice, SCID | 1 | 2020 | 589 | 0.040 |
Why?
|
| Disease Susceptibility | 1 | 2020 | 277 | 0.040 |
Why?
|
| Mass Spectrometry | 1 | 2020 | 361 | 0.040 |
Why?
|
| Cell Line, Tumor | 1 | 2025 | 3720 | 0.030 |
Why?
|
| Up-Regulation | 1 | 2020 | 835 | 0.030 |
Why?
|
| Immunoglobulin G | 1 | 2020 | 790 | 0.030 |
Why?
|
| Bone Marrow | 1 | 2018 | 319 | 0.030 |
Why?
|
| Monocytes | 1 | 2018 | 336 | 0.030 |
Why?
|
| Lipids | 1 | 2020 | 563 | 0.030 |
Why?
|
| Liver | 1 | 2023 | 1797 | 0.030 |
Why?
|
| Cells, Cultured | 1 | 2021 | 2905 | 0.030 |
Why?
|
| Genetic Variation | 1 | 2020 | 1553 | 0.020 |
Why?
|
| Transcriptome | 1 | 2020 | 1129 | 0.020 |
Why?
|
| Female | 3 | 2026 | 70322 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2021 | 4660 | 0.020 |
Why?
|
| Male | 1 | 2025 | 64563 | 0.010 |
Why?
|